{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:04:19Z","timestamp":1791295459771,"version":"4.1.0"},"reference-count":71,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,2,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Chronic neutrophilic leukemia (CNL) is a distinct myeloproliferative neoplasm with a high prevalence (&gt;80%) of mutations in the colony-stimulating factor 3 receptor (CSF3R). These mutations activate the receptor, leading to the proliferation of neutrophils that are a hallmark of CNL. Recently, the World Health Organization guidelines have been updated to include CSF3R mutations as part of the diagnostic criteria for CNL. Because of the high prevalence of CSF3R mutations in CNL, it is tempting to think of this disease as being solely driven by this genetic lesion. However, recent additional genomic characterization demonstrates that CNL has much in common with other chronic myeloid malignancies at the genetic level, such as the clinically related diagnosis atypical chronic myeloid leukemia. These commonalities include mutations in SETBP1, spliceosome proteins (SRSF2, U2AF1), and epigenetic modifiers (TET2, ASXL1). Some of these same mutations also have been characterized as frequent events in clonal hematopoiesis of indeterminate potential, suggesting a more complex disease evolution than was previously understood and raising the possibility that an age-related clonal process of preleukemic cells could precede the development of CNL. The order of acquisition of CSF3R mutations relative to mutations in SETBP1, epigenetic modifiers, or the spliceosome has been determined only in isolated case reports; thus, further work is needed to understand the impact of mutation chronology on the clonal evolution and progression of CNL. Understanding the complete landscape and chronology of genomic events in CNL will help in the development of improved therapeutic strategies for this patient population.<\/jats:p>","DOI":"10.1182\/blood-2016-10-695981","type":"journal-article","created":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T21:00:18Z","timestamp":1482872418000},"page":"715-722","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":88,"title":["Genomics of chronic neutrophilic leukemia"],"prefix":"10.1182","volume":"129","author":[{"given":"Julia E.","family":"Maxson","sequence":"first","affiliation":[{"name":"Division of Hematology and Medical Oncology,"},{"name":"Knight Cancer Institute, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey W.","family":"Tyner","sequence":"additional","affiliation":[{"name":"Knight Cancer Institute, and"},{"name":"Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111903144325000_B1","first-page":"85","article-title":"Chromosome studies on normal and leukemic human leukocytes","volume":"25","author":"Nowell","year":"1960","journal-title":"J Natl Cancer Inst"},{"issue":"5405","key":"2019111903144325000_B2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"issue":"1","key":"2019111903144325000_B3","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1128\/MCB.5.1.204","article-title":"Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties","volume":"5","author":"Davis","year":"1985","journal-title":"Mol Cell Biol"},{"issue":"4760","key":"2019111903144325000_B4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1126\/science.3460176","article-title":"The chronic myelogenous leukemia-specific P210 protein is the product of the bcr\/abl hybrid gene","volume":"233","author":"Ben-Neriah","year":"1986","journal-title":"Science"},{"issue":"6020","key":"2019111903144325000_B5","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/315550a0","article-title":"Fused transcript of abl and bcr genes in chronic myelogenous leukaemia","volume":"315","author":"Shtivelman","year":"1985","journal-title":"Nature"},{"issue":"13","key":"2019111903144325000_B6","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","article-title":"Translation of the Philadelphia chromosome into therapy for CML","volume":"112","author":"Druker","year":"2008","journal-title":"Blood"},{"key":"2019111903144325000_B7","article-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"key":"2019111903144325000_B8","article-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Vol. 2","author":"Swerdlow","year":"2014"},{"issue":"10","key":"2019111903144325000_B9","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1182\/blood-2013-05-500959","article-title":"The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment","volume":"122","author":"Gotlib","year":"2013","journal-title":"Blood"},{"issue":"3","key":"2019111903144325000_B10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ajh.24284","article-title":"Chronic neutrophilic leukemia 2016: Update on diagnosis, molecular genetics, prognosis, and management","volume":"91","author":"Elliott","year":"2016","journal-title":"Am J Hematol"},{"issue":"2","key":"2019111903144325000_B11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2403562","article-title":"WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literature","volume":"19","author":"Elliott","year":"2005","journal-title":"Leukemia"},{"issue":"9","key":"2019111903144325000_B12","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1038\/leu.2013.122","article-title":"CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia","volume":"27","author":"Pardanani","year":"2013","journal-title":"Leukemia"},{"issue":"11","key":"2019111903144325000_B13","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/jcp.55.11.862","article-title":"Chronic neutrophilic leukaemia: 14 new cases of an uncommon myeloproliferative disease","volume":"55","author":"B\u00f6hm","year":"2002","journal-title":"J Clin Pathol"},{"issue":"19","key":"2019111903144325000_B14","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1214514","article-title":"Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML","volume":"368","author":"Maxson","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"2019111903144325000_B15","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nri3660","article-title":"Emergency granulopoiesis","volume":"14","author":"Manz","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"22","key":"2019111903144325000_B16","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1182\/blood-2012-01-406116","article-title":"Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia","volume":"119","author":"Beekman","year":"2012","journal-title":"Blood"},{"issue":"9","key":"2019111903144325000_B17","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1074\/jbc.M113.508440","article-title":"Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization","volume":"289","author":"Maxson","year":"2014","journal-title":"J Biol Chem"},{"issue":"22","key":"2019111903144325000_B18","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1182\/blood-2013-06-509976","article-title":"The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition","volume":"122","author":"Fleischman","year":"2013","journal-title":"Blood"},{"issue":"3","key":"2019111903144325000_B19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1158\/1078-0432.CCR-14-3100","article-title":"The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I","volume":"22","author":"Maxson","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2019111903144325000_B20","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20090693","article-title":"An activating mutation in the CSF3R gene induces a hereditary chronic neutrophilia","volume":"206","author":"Plo","year":"2009","journal-title":"J Exp Med"},{"issue":"10","key":"2019111903144325000_B21","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1073\/pnas.91.10.4480","article-title":"Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia","volume":"91","author":"Dong","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"2019111903144325000_B22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJM199508243330804","article-title":"Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia","volume":"333","author":"Dong","year":"1995","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111903144325000_B23","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.4049\/jimmunol.169.3.1219","article-title":"Suppressor of cytokine signaling-3 is recruited to the activated granulocyte-colony stimulating factor receptor and modulates its signal transduction","volume":"169","author":"H\u00f6rtner","year":"2002","journal-title":"J Immunol"},{"issue":"7","key":"2019111903144325000_B24","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1182\/blood-2002-07-2062","article-title":"Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor receptor orchestrate G-CSF-induced expansion of myeloid progenitor cells","volume":"101","author":"Hermans","year":"2003","journal-title":"Blood"},{"issue":"3","key":"2019111903144325000_B25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood-2003-08-2913","article-title":"G-CSF receptor truncations found in SCN\/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact","volume":"104","author":"van de Geijn","year":"2004","journal-title":"Blood"},{"issue":"7","key":"2019111903144325000_B26","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/sj.emboj.7601640","article-title":"Suppressor of cytokine signaling 3 controls lysosomal routing of G-CSF receptor","volume":"26","author":"Irandoust","year":"2007","journal-title":"EMBO J"},{"issue":"2","key":"2019111903144325000_B27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/blood-2003-07-2250","article-title":"Receptor activation and 2 distinct COOH-terminal motifs control G-CSF receptor distribution and internalization kinetics","volume":"103","author":"Aarts","year":"2004","journal-title":"Blood"},{"issue":"8","key":"2019111903144325000_B28","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1182\/blood.V101.8.2990","article-title":"Impaired neutrophil maturation in truncated murine G-CSF receptor-transgenic mice","volume":"101","author":"Mitsui","year":"2003","journal-title":"Blood"},{"issue":"1","key":"2019111903144325000_B29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1182\/blood.V92.1.32.413k42_32_39","article-title":"Perturbed granulopoiesis in mice with a targeted mutation in the granulocyte colony-stimulating factor receptor gene associated with severe chronic neutropenia","volume":"92","author":"Hermans","year":"1998","journal-title":"Blood"},{"issue":"12","key":"2019111903144325000_B30","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.exphem.2011.08.013","article-title":"A truncation mutant of Csf3r cooperates with PML-RAR\u03b1 to induce acute myeloid leukemia in mice","volume":"39","author":"Kunter","year":"2011","journal-title":"Exp Hematol"},{"issue":"12","key":"2019111903144325000_B31","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.3324\/haematol.2014.113159","article-title":"Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia","volume":"99","author":"Meggendorfer","year":"2014","journal-title":"Haematologica"},{"issue":"17","key":"2019111903144325000_B32","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood-2014-02-553800","article-title":"Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic\/myeloproliferative neoplasms","volume":"123","author":"Wang","year":"2014","journal-title":"Blood"},{"issue":"5","key":"2019111903144325000_B33","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.3324\/haematol.2013.085050","article-title":"Prevalence of a new auto-activating colony stimulating factor 3 receptor mutation (CSF3R-T595I) in acute myeloid leukemia and severe congenital neutropenia","volume":"98","author":"Beekman","year":"2013","journal-title":"Haematologica"},{"issue":"3","key":"2019111903144325000_B34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/bjh.13439","article-title":"CSF3R and CALR mutations in paediatric myeloid disorders and the association of CSF3R mutations with translocations, including t(8; 21)","volume":"170","author":"Sano","year":"2015","journal-title":"Br J Haematol"},{"issue":"24","key":"2019111903144325000_B35","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1182\/blood-2016-04-709899","article-title":"CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML","volume":"127","author":"Maxson","year":"2016","journal-title":"Blood"},{"issue":"24","key":"2019111903144325000_B36","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1182\/blood-2016-03-705053","article-title":"Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors","volume":"127","author":"Lavall\u00e9e","year":"2016","journal-title":"Blood"},{"issue":"9","key":"2019111903144325000_B37","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1038\/leu.2013.182","article-title":"Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia","volume":"27","author":"Kosmider","year":"2013","journal-title":"Leukemia"},{"issue":"20","key":"2019111903144325000_B38","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2019111903144325000_B39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ng.2495","article-title":"Recurrent SETBP1 mutations in atypical chronic myeloid leukemia","volume":"45","author":"Piazza","year":"2013","journal-title":"Nat Genet"},{"key":"2019111903144325000_B40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13045-014-0077-1","article-title":"CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia","volume":"7","author":"Cui","year":"2014","journal-title":"J Hematol Oncol"},{"issue":"5","key":"2019111903144325000_B41","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1046\/j.1432-1327.2001.02000.x","article-title":"Identification and characterization of SEB, a novel protein that binds to the acute undifferentiated leukemia-associated protein SET","volume":"268","author":"Minakuchi","year":"2001","journal-title":"Eur J Biochem"},{"issue":"8","key":"2019111903144325000_B42","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1128\/MCB.12.8.3346","article-title":"Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3\u2032 half to different genes: characterization of the set gene","volume":"12","author":"von Lindern","year":"1992","journal-title":"Mol Cell Biol"},{"issue":"19","key":"2019111903144325000_B43","doi-asserted-by":"crossref","first-page":"11059","DOI":"10.1074\/jbc.271.19.11059","article-title":"The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A","volume":"271","author":"Li","year":"1996","journal-title":"J Biol Chem"},{"issue":"3","key":"2019111903144325000_B44","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1182\/blood-2009-06-227363","article-title":"SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia","volume":"115","author":"Crist\u00f3bal","year":"2010","journal-title":"Blood"},{"issue":"6","key":"2019111903144325000_B45","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/ng.581","article-title":"De novo mutations of SETBP1 cause Schinzel-Giedion syndrome","volume":"42","author":"Hoischen","year":"2010","journal-title":"Nat Genet"},{"issue":"1","key":"2019111903144325000_B46","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/leu.2015.200","article-title":"Runx1 repression by histone deacetylation is critical for Setbp1-induced mouse myeloid leukemia development","volume":"30","author":"Vishwakarma","year":"2016","journal-title":"Leukemia"},{"issue":"8","key":"2019111903144325000_B47","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ng.2696","article-title":"Somatic SETBP1 mutations in myeloid malignancies","volume":"45","author":"Makishima","year":"2013","journal-title":"Nat Genet"},{"issue":"8","key":"2019111903144325000_B48","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/ng.2698","article-title":"Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia","volume":"45","author":"Sakaguchi","year":"2013","journal-title":"Nat Genet"},{"issue":"10","key":"2019111903144325000_B49","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1038\/leu.2013.145","article-title":"SETBP1 mutation analysis in 944 patients with MDS and AML","volume":"27","author":"Thol","year":"2013","journal-title":"Leukemia"},{"issue":"10","key":"2019111903144325000_B50","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/leu.2013.97","article-title":"SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML","volume":"27","author":"Laborde","year":"2013","journal-title":"Leukemia"},{"issue":"6","key":"2019111903144325000_B51","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/leu.2013.35","article-title":"SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias","volume":"27","author":"Damm","year":"2013","journal-title":"Leukemia"},{"issue":"15","key":"2019111903144325000_B52","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","article-title":"Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts","volume":"365","author":"Papaemmanuil","year":"2011","journal-title":"N Engl J Med"},{"issue":"26","key":"2019111903144325000_B53","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","article-title":"SF3B1 and other novel cancer genes in chronic lymphocytic leukemia","volume":"365","author":"Wang","year":"2011","journal-title":"N Engl J Med"},{"issue":"7367","key":"2019111903144325000_B54","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia","volume":"478","author":"Yoshida","year":"2011","journal-title":"Nature"},{"issue":"15","key":"2019111903144325000_B55","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/blood-2012-01-404863","article-title":"SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)","volume":"120","author":"Meggendorfer","year":"2012","journal-title":"Blood"},{"issue":"22","key":"2019111903144325000_B56","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"N Engl J Med"},{"key":"2019111903144325000_B57","first-page":"264","article-title":"What's different about atypical CML and chronic neutrophilic leukemia?","volume-title":"Hematology Am Soc Hematol Educ Program","author":"Dao","year":"2015"},{"issue":"7","key":"2019111903144325000_B58","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/ajh.24031","article-title":"ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia","volume":"90","author":"Elliott","year":"2015","journal-title":"Am J Hematol"},{"issue":"24","key":"2019111903144325000_B59","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1182\/blood-2008-12-194548","article-title":"Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms","volume":"113","author":"Grand","year":"2009","journal-title":"Blood"},{"issue":"3","key":"2019111903144325000_B60","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1182\/blood-2014-06-579466","article-title":"Recurrent ETNK1 mutations in atypical chronic myeloid leukemia","volume":"125","author":"Gambacorti-Passerini","year":"2015","journal-title":"Blood"},{"key":"2019111903144325000_B61","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1038\/bcj.2014.94","article-title":"Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia","volume":"5","author":"Lasho","year":"2015","journal-title":"Blood Cancer J"},{"issue":"11","key":"2019111903144325000_B62","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/ng.2413","article-title":"Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis","volume":"44","author":"Busque","year":"2012","journal-title":"Nat Genet"},{"issue":"12","key":"2019111903144325000_B63","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"issue":"26","key":"2019111903144325000_B64","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"26","key":"2019111903144325000_B65","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"issue":"7","key":"2019111903144325000_B66","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMoa1412098","article-title":"Effect of mutation order on myeloproliferative neoplasms","volume":"372","author":"Ortmann","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111903144325000_B67","first-page":"67","article-title":"Significant clinical response to JAK1\/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia","volume":"3","author":"Dao","year":"2014","journal-title":"Leuk Res Rep"},{"issue":"1","key":"2019111903144325000_B68","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/pbc.25694","article-title":"Atypical Chronic Myeloid Leukemia in Two Pediatric Patients","volume":"63","author":"Freedman","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"2019111903144325000_B69","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00277-016-2664-4","article-title":"Clinical response to ruxolitinib in CSF3R T618-mutated chronic neutrophilic leukemia","volume":"95","author":"Stahl","year":"2016","journal-title":"Ann Hematol"},{"issue":"5","key":"2019111903144325000_B70","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00277-014-2272-0","article-title":"Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib","volume":"94","author":"Ammatuna","year":"2015","journal-title":"Ann Hematol"},{"issue":"6","key":"2019111903144325000_B71","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/leu.2014.39","article-title":"Chronic neutrophilic leukemia with concurrent CSF3R and SETBP1 mutations: single colony clonality studies, in vitro sensitivity to JAK inhibitors and lack of treatment response to ruxolitinib","volume":"28","author":"Lasho","year":"2014","journal-title":"Leukemia"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/6\/715\/1401657\/blood695981.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/6\/715\/1401657\/blood695981.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T03:15:14Z","timestamp":1574133314000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/6\/715\/36321\/Genomics-of-chronic-neutrophilic-leukemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,9]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,2,9]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-10-695981","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,9]]}}}